1 NO. NCH 024/2562 July 11, 2019 Subject : Notice of setting up a new subsidiary under joint venture agreement to cover intermediate care and wellness business Attn. : Director and Manager The Stock

Microsoft Word - MD&A_Q2_2019_EN 14.8.19 1 NPPG.050/2562 August 14th, 2019 Subject Management’s analysis for the 2nd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s

19 September 2005 - Translate – Ref. HF 0109/2018 August 6th, 2018. Subject : Disclosure of Connected Transaction. Attn : Managing Director of the Stock Exchange of Thailand. According to the

No. : 0107535000371 No. L039/2018 7th August 2018 Subject : The explanation of operating results for the 2nd quarter 2018 Attention : The President The Stock Exchange of Thailand Dear Sir, For the

19 September 2005 - Translate – Ref. HF 0109/2018 August 6th, 2018. Subject : Disclosure of Connected Transaction (Additional) Attn : Managing Director of the Stock Exchange of Thailand. According to

/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

-1- November 29, 2018 Subject Change of payment method for investment in acquisition and sale of tap water in some areas of Phuket and some areas of Phangnga. To Director and Manager The Stock

(Translation) Ref: EIC-AD043/2019 13 November 2019 Subject: Management Discussion and Analysis for the Performance for Nine-Month Period ended 30 September2019 To: President The Stock Exchange of Thailand The

-9320 1 Ref: PLC 2019/011 November 13, 2019 Subject: Management Discussion and Analysis Quarter 3 Ended 30 September 2019 To: The President of the Stock Exchange of Thailand Panjawattana Plastic Public

IDH-AC-000-อส6302/30.00 20 February 2020 Re: Management Discussion and Analysis Operating results for the year ended 31 December 2019 To: President The Stock Exchange of Thailand Overview of the